This invention relates to a luminescent
lanthanide chelate comprising a
lanthanide ion and a chelating ligand of formula (I) whereinR1 is selected from the group consisting H, —COOH, —COO−, —CH2COOH and —CH2COO−; G1 is a group consisting of one or two moieties each
moiety being selected from the group consisting of ethynediyl, ethenylene,
phenylene, biphenylene, naphthylene, pyridylene, pyrazinylene, pyrimidinylene, pyridazinylene, furylene, thienylene, pyrrolylene, imidazolylene, pyrazolylene, thiazolylene, isothiazolylene, oxazolylene, isoxazolylene, fyrazanylene, 1,2,4-triazol-3,5-ylene and oxadiazolylene; G2 for
coupling to a biospecific binding reactant is selected from the group consisting of amino, aminooxy, carbonyl,
aldehyde or mercapto groups and activated forms made of them; Z is selected from the group consisting of carboxyalkyl amine,
ether,
thioether, carbonyl and unsubstituted or substitute methyl (—CR2—) wherein group R2 is selected from the group consisting of H, methyl, ethyl and carboxylalkyl; and the
lanthanide ion is
europium(III),
terbium(III), dysprosiym(III) or
samarium(III). This invention further relates to a detectable molecule comprising the lanthanide chelate and the use of the molecule in a method of carrying out a biospecific binding
assay.